Literature DB >> 8878036

Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12.

D L Gally1, J Leathart, I C Blomfield.   

Abstract

The phase variation of type 1 fimbriae in Escherichia coli is associated with the site-specific inversion of a short DNA element. Recombination at fim requires fimB and fimE, and their products are considered to be the fim recombinases. In this study, FimB and FimE were overproduced and extracts containing the proteins were shown to (i) bind to and (ii) invert the fim switch in vitro. Phenanthroline-copper protection of DNA-protein complexes showed that both FimB and FimE bind to half-sites that flank, and overlap with, the left and right inverted repeats (IRL and IRR, respectively) of the fim switch. Alignment of the four half-sites identified a conserved 5'-CA doublet; mutation of these two bases lowers the affinity of binding of both FimB and FimE to the inverted repeats, and greatly diminishes inversion of the fim switch in vivo. The specificity of the fim recombinases observed in vivo (FimB switching in both directions; FimE switching from on-to-off only) was maintained in vitro. Furthermore, the different binding affinities of FimB and FimE for the various half-site combinations suggests that the specificity of FimE could arise, in part, from the low affinity of FimE for IRL (off).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878036     DOI: 10.1046/j.1365-2958.1996.311388.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  71 in total

1.  Type 1 fimbriation and phase switching in a natural Escherichia coli fimB null strain, Nissle 1917.

Authors:  B Stentebjerg-Olesen; T Chakraborty; P Klemm
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

2.  Interaction of the FimB integrase with the fimS invertible DNA element in Escherichia coli in vivo and in vitro.

Authors:  L S Burns; S G Smith; C J Dorman
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

3.  Antigen 43 and type 1 fimbriae determine colony morphology of Escherichia coli K-12.

Authors:  H Hasman; M A Schembri; P Klemm
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

4.  Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Corinne K Cusumano; Thomas J Hannan; James W Janetka; Scott J Hultgren
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

5.  Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.

Authors:  Sébastien Crépin; Sébastien Houle; Marie-Ève Charbonneau; Michaël Mourez; Josée Harel; Charles M Dozois
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

Review 6.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

7.  What does it take to stick around? Molecular insights into biofilm formation by uropathogenic Escherichia coli.

Authors:  Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

8.  Modulation of the sensitivity of FimB recombination to branched-chain amino acids and alanine in Escherichia coli K-12.

Authors:  Maryam Lahooti; Paula L Roesch; Ian C Blomfield
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

Review 9.  Escherichia coli biofilms.

Authors:  C Beloin; A Roux; J M Ghigo
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

10.  Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.

Authors:  Swaine L Chen; Chia S Hung; Jerome S Pinkner; Jennifer N Walker; Corinne K Cusumano; Zhaoli Li; Julie Bouckaert; Jeffrey I Gordon; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.